Medical Enterprise Value Over E B I T D A from 2010 to 2024

MPW Stock  USD 4.64  0.12  2.65%   
Medical Properties Enterprise Value Over EBITDA yearly trend continues to be fairly stable with very little volatility. Enterprise Value Over EBITDA will likely drop to 17.82 in 2024. During the period from 2010 to 2024, Medical Properties Enterprise Value Over EBITDA regression line of quarterly data had mean square error of  23.62 and geometric mean of  16.44. View All Fundamentals
 
Enterprise Value Over EBITDA  
First Reported
2010-12-31
Previous Quarter
18.77865486
Current Value
17.82
Quarterly Volatility
4.70718852
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Medical Properties financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medical main balance sheet or income statement drivers, such as Depreciation And Amortization of 633.5 M, Interest Expense of 390.6 M or Selling General Administrative of 152.9 M, as well as many exotic indicators such as Price To Sales Ratio of 3.2, Dividend Yield of 0.22 or PTB Ratio of 0.37. Medical financial statements analysis is a perfect complement when working with Medical Properties Valuation or Volatility modules.
  
This module can also supplement Medical Properties' financial leverage analysis and stock options assessment as well as various Medical Properties Technical models . Check out the analysis of Medical Properties Correlation against competitors.

Latest Medical Properties' Enterprise Value Over E B I T D A Growth Pattern

Below is the plot of the Enterprise Value Over E B I T D A of Medical Properties Trust over the last few years. It is Medical Properties' Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medical Properties' overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Over E B I T D A10 Years Trend
Very volatile
   Enterprise Value Over E B I T D A   
       Timeline  

Medical Enterprise Value Over E B I T D A Regression Statistics

Arithmetic Mean17.14
Geometric Mean16.44
Coefficient Of Variation27.46
Mean Deviation3.19
Median16.92
Standard Deviation4.71
Sample Variance22.16
Range21.4669
R-Value(0.10)
Mean Square Error23.62
R-Squared0.01
Significance0.72
Slope(0.11)
Total Sum of Squares310.21

Medical Enterprise Value Over E B I T D A History

2024 17.82
2023 18.78
2022 16.64
2021 19.04
2020 17.94
2019 20.59
2018 6.6

About Medical Properties Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Medical Properties income statement, its balance sheet, and the statement of cash flows. Medical Properties investors use historical funamental indicators, such as Medical Properties's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Medical Properties investors may use each financial statement separately, they are all related. The changes in Medical Properties's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Medical Properties's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Medical Properties Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Medical Properties. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Over EBITDA 18.78  17.82 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Medical Properties Trust is a strong investment it is important to analyze Medical Properties' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medical Properties' future performance. For an informed investment choice regarding Medical Stock, refer to the following important reports:
Check out the analysis of Medical Properties Correlation against competitors.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Medical Stock analysis

When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Valuation
Check real value of public entities based on technical and fundamental data
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Is Medical Properties' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medical Properties. If investors know Medical will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medical Properties listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.49)
Dividend Share
0.88
Earnings Share
(0.93)
Revenue Per Share
1.48
Quarterly Revenue Growth
(0.13)
The market value of Medical Properties Trust is measured differently than its book value, which is the value of Medical that is recorded on the company's balance sheet. Investors also form their own opinion of Medical Properties' value that differs from its market value or its book value, called intrinsic value, which is Medical Properties' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medical Properties' market value can be influenced by many factors that don't directly affect Medical Properties' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medical Properties' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medical Properties is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medical Properties' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.